osimertinib
astrazeneca
['lung', 'osimertinib']
a phase ii study of osimertinib in combination with platinum plus pemetrexed in patients with egfr-mutated, advanced non small cell lung cancer: the opal study #asco22 orr 90.9% 
Medicina Interna - Oncología Clínica - Profesor Titular @UPBColombia - Clínica Astorga. #Medellín / #Colombia mlujanonco@gmail.com #OncTwitter #Metaanalysis